Search / Trial NCT06226935

Comparative Analysis of Glaucoma Screening Uptake Among First-Degree Relatives in Community-Based and Hospital-Based Approaches

Launched by PHRAPOKKLAO HOSPITAL,THAILAND · Jan 18, 2024

Trial Information

Current as of October 03, 2024

Completed

Keywords

Glaucoma Screening First Degree Relatives Community Based Approach Hospital Based Approach Familial Risk Factors

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * All patients with POAG who had a treatment history in the ophthalmology outpatient department of Prapokklao Hospital, Chanthaburi Province, were identified from the Electronic Medical Record (EMR) database with the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) " Primary open angle glaucoma H40.1" between 1 january 2022 to 31 october 2022. A total of 1304 patients were included in this study.
  • Exclusion Criteria:
  • * Excluding those with closed-angle glaucoma and secondary glaucoma due to other conditions such as accidents, post-surgical complications, uveitis, or congenital.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Chanthaburi, , Thailand

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0